Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients

MI JIN OH, DONG-YEOP SHIN, YOUNGIL KOH, JUNSHIK HONG, INHO KIM, SUNG-SOO YOON and JA MIN BYUN
In Vivo January 2021, 35 (1) 617-622; DOI: https://doi.org/10.21873/invivo.12299
MI JIN OH
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DONG-YEOP SHIN
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOUNGIL KOH
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNSHIK HONG
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INHO KIM
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNG-SOO YOON
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JA MIN BYUN
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jaminbyun@naver.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 1 617-622
DOI 
https://doi.org/10.21873/invivo.12299
PubMed 
33402517

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received October 24, 2020
  • Revision received November 23, 2020
  • Accepted November 24, 2020
  • Published online January 5, 2021.

Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MI JIN OH1,
  2. DONG-YEOP SHIN1,2,3,
  3. YOUNGIL KOH1,2,3,
  4. JUNSHIK HONG1,2,3,
  5. INHO KIM1,
  6. SUNG-SOO YOON1,2,3 and
  7. JA MIN BYUN1,2,3⇑
  1. 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea;
  2. 2Cancer Research Institute, Seoul National University Hospital, Seoul, Republic of Korea;
  3. 3Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea
  1. Correspondence to: Ja Min Byun, MD, Ph.D., Department of Internal Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongro-gu, Seoul 03080, Republic of Korea. Tel: +82 220721477, Fax: +82 27629662, e-mail: jaminbyun{at}naver.com
View Full Text
PreviousNext
Back to top

In this issue

In Vivo: 35 (1)
In Vivo
Vol. 35, Issue 1
January-February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients
MI JIN OH, DONG-YEOP SHIN, YOUNGIL KOH, JUNSHIK HONG, INHO KIM, SUNG-SOO YOON, JA MIN BYUN
In Vivo Jan 2021, 35 (1) 617-622; DOI: 10.21873/invivo.12299

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients
MI JIN OH, DONG-YEOP SHIN, YOUNGIL KOH, JUNSHIK HONG, INHO KIM, SUNG-SOO YOON, JA MIN BYUN
In Vivo Jan 2021, 35 (1) 617-622; DOI: 10.21873/invivo.12299
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
  • A Finnish Version of RAND-36-Item Health Survey Versus Structured Interview 8 Years Postoperatively
  • Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Acute myeloid leukemia
  • intermediate risk
  • allogeneic hematopoietic stem cell transplantation
In Vivo

© 2021 In Vivo

Powered by HighWire